Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development

The serine/threonine protein kinase AKT plays a pivotal role within the PI3K pathway in regulating cellular proliferation and apoptotic cellular functions, and AKT hyper-activation via gene amplification and/or mutation has been implicated in multiple human malignancies. There are 3 AKT isoenzymes (AKT1-3) which mediate critical, non-redundant functions. We present the discovery and development of ALM301, a novel, allosteric, sub-type selective inhibitor of AKT1/2. ALM301 binds in an allosteric pocket created by the combined movement of the PH domain and the catalytic domain, resulting in a DFG out conformation. ALM301 was shown to be highly selective against a panel of over 450 kinases and potently inhibited cellular proliferation. These effects were particularly pronounced in MCF-7 cells containing a PI3KCA mutation. Subsequent cellular downstream pathway analysis in this sensitive cell line revealed potent inhibition of pAKT signalling up to 48 h post dosing. ALM301 treatment was well tolerated in an MCF-7 xenograft model and led to a dose-dependent reduction in tumour growth. Enhanced efficacy was observed in combination with tamoxifen. In summary, ALM301 is a highly specific AKT 1/2 inhibitor with an excellent pharmacological profile suitable for further clinical development.

Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors

Ubiquitin specific protease 7 (USP7, HAUSP) has become an attractive target in drug discovery due to the role it plays in modulating Mdm2 levels and consequently p53. Increasing interest in USP7 is emerging due to its potential involvement in oncogenic pathways as well as possible roles in both metabolic and immune disorders in addition to viral infections. Potent, novel, and selective inhibitors of USP7 have been developed using both rational and structure-guided design enabled by high-resolution cocrystallography. Initial hits were identified via fragment-based screening, scaffold-hopping, and hybridization exercises. Two distinct subseries are described along with associated structure-activity relationship trends, as are initial efforts aimed at developing compounds suitable for in vivo experiments. Overall, these discoveries will enable further research into the wider biological role of USP7.

Synthesis and in vitro and in vivo evaluation of a series of dihydroisocoumarin derivatives conjugated with fatty acids, alcohols, and amines as potential anticancer agents

In this paper, we report the synthesis and biological activity of a series of dihydroisocoumarin analogues conjugated with fatty acids, alcohols, or amines, of varying hydrocarbon chain length and degree of unsaturation, to the dihydroisocoumarins, kigelin and mellein, at the C-7 and C-8 positions on the core dihydroisocoumarin structure. These compounds were evaluated for their antiproliferative activity against human breast cancer (MCF-7 and MDA-MB-468) and melanoma cells (SK-MEL-28 and Malme-3M) using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Two compounds conjugated with gamma-linolenyl alcohol (18:3 n-6) demonstrated potent antiproliferative activity in vitro with one of these 4-hydroxy-3-oxo-1,3-dihydro-isobenzofuran-5-carboxylic acid octadeca-6,9,12-trienyl ester, demonstrating significant antitumor activity in vivo in a number of human tumor xenograft models.

Abstract A175: Isolation and identification of compounds from the fruits of Kigelia pinnata with anti-proliferative activity towards human cancer cells

Kigelia pinnata DC. (Bignoniaceae also referred to as K. Africana or sausage tree), is a tree which is found widely in Africa and the tropics in general. Traditionally hot aqueous extracts of fruit pods from Kigelia pinnata have been claimed to have widespread ethnomedicinal importance. A preliminary study of the components of the aqueous extracts from the fruits of Kigelia pinnata was undertaken to identify fractions with potential anti-cancer activity. A bioactivity guided fractionation process of extracts from fruits of the tree was carried out yielding a number of crude fractions, which demonstrated cytotoxicity in vitro against human melanoma cells. A number of compounds were isolated and identified within purified fractions of several fruit extracts including the dihydroisocoumarins, demethylkigelin and kigelin, a number of fatty acids, and a furonaphthoquinone, as compounds at least in part responsible for the anti-proliferative activity observed in extracted material from the fruits. We tested a number of structurally related dihydroisocoumarins for their anti-proliferative activity in order to conduct a preliminary structure-activity relationship (SAR) study. The preliminary medicinal chemistry programme clearly identified structures with enhanced anti-proliferative activity relative to the isolated compounds. In conclusion, using a bioassay fractionation approach, we have isolated and characterized several classes of compounds that exhibit biological activity against human cancer cell lines. Structurally-related derivatives of these compounds have been synthesized to develop knowledge of the structure-activity relationship for these classes of compounds. Our data to date suggest that this class of molecule has structural features that appear to be of importance in determining its activity against human cancer cells.

Citation Information: Mol Cancer Ther 2009;8(12 Suppl):A175.